1. Home
  2. IDYA vs BFH Comparison

IDYA vs BFH Comparison

Compare IDYA & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$34.67

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

N/A

Current Price

$72.18

Market Cap

3.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
BFH
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IDYA
BFH
Price
$34.67
$72.18
Analyst Decision
Strong Buy
Hold
Analyst Count
14
17
Target Price
$49.33
$70.20
AVG Volume (30 Days)
964.1K
885.5K
Earning Date
02-12-2026
01-29-2026
Dividend Yield
N/A
1.25%
EPS Growth
N/A
55.00
EPS
N/A
9.68
Revenue
$214,834,000.00
$2,509,000,000.00
Revenue This Year
$2,688.43
$58.62
Revenue Next Year
N/A
$3.51
P/E Ratio
N/A
$7.61
Revenue Growth
5377.66
1.70
52 Week Low
$13.45
$38.21
52 Week High
$39.28
$82.03

Technical Indicators

Market Signals
Indicator
IDYA
BFH
Relative Strength Index (RSI) 47.60 46.43
Support Level $34.75 $67.78
Resistance Level $37.81 $74.17
Average True Range (ATR) 1.70 2.16
MACD -0.16 -1.01
Stochastic Oscillator 31.09 30.88

Price Performance

Historical Comparison
IDYA
BFH

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

Share on Social Networks: